首页 > 最新文献

Photodiagnosis and Photodynamic Therapy最新文献

英文 中文
Clinical efficacy of curettage combined with 5-aminolevulinic acid photodynamic therapy in treating recalcitrant acral warts 刮痧联合5-氨基乙酰丙酸光动力疗法治疗顽固性肢端疣的临床疗效。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-31 DOI: 10.1016/j.pdpdt.2026.105373
Long Zhang , Yang He , Juan Yuan , Wen Ding , Xia Lei , Qionghui Cheng , Nian Chen

Background and Objectives

Viral warts are benign proliferative skin lesions caused by the human papillomavirus (HPV) and are contagious among humans. Currently, there are no effective treatments to address the high recurrence rate of viral warts, presenting challenges in achieving their complete eradication. The aim of this study was to evaluate the efficacy and safety of curettage combined with 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for the treatment of recalcitrant acral warts.

Methods

Our study was carried out between July 2023 to June 2025, and the clinical data of 50 patients diagnosed with acral warts were retrospectively collected. Patients were assigned to the curettage group (n = 24) or the combination group (n = 26) based on whether they received photodynamic therapy after curettage. The clinical response effects, recurrence rate and adverse reactions of the two groups were observed and compared.

Results

The cure rate in the combination group was 80.8% (21/26), which was significantly higher than 45.8% (11/24) in curettage group. The recurrence rate in the combination group was 19.2% (5/26), which was lower than 54.2% (13/24) in curettage group (P < 0.05). After three months of follow-up, moderate pain was the main adverse reaction in both groups, and no systemic adverse reactions were observed.

Conclusion

Our results suggest that curettage combined with ALA-PDT is promising as a safe and effective therapy for patients with recalcitrant acral warts.
背景和目的:病毒性疣是由人乳头瘤病毒(HPV)引起的良性增生性皮肤病变,在人与人之间具有传染性。目前,没有有效的治疗方法来解决病毒性疣的高复发率,在实现其完全根除方面提出了挑战。本研究的目的是评价刮痧联合5-氨基乙酰丙酸光动力疗法(ALA-PDT)治疗顽固性肢端疣的疗效和安全性。方法:我们的研究于2023年7月至2025年6月进行,回顾性收集50例诊断为肢端疣的患者的临床资料。根据患者在刮痧后是否接受光动力治疗分为刮痧组(n=24)和联合组(n=26)。观察比较两组患者的临床疗效、复发率及不良反应。结果:联合组治愈率为80.8%(21/26),显著高于刮治组45.8%(11/24)。联合组的复发率为19.2%(5/26),低于刮痧组的54.2%(13/24)。结论:刮痧联合ALA-PDT治疗顽固性肢端疣是一种安全有效的治疗方法。
{"title":"Clinical efficacy of curettage combined with 5-aminolevulinic acid photodynamic therapy in treating recalcitrant acral warts","authors":"Long Zhang ,&nbsp;Yang He ,&nbsp;Juan Yuan ,&nbsp;Wen Ding ,&nbsp;Xia Lei ,&nbsp;Qionghui Cheng ,&nbsp;Nian Chen","doi":"10.1016/j.pdpdt.2026.105373","DOIUrl":"10.1016/j.pdpdt.2026.105373","url":null,"abstract":"<div><h3>Background and Objectives</h3><div>Viral warts are benign proliferative skin lesions caused by the human papillomavirus (HPV) and are contagious among humans. Currently, there are no effective treatments to address the high recurrence rate of viral warts, presenting challenges in achieving their complete eradication. The aim of this study was to evaluate the efficacy and safety of curettage combined with 5-aminolevulinic acid photodynamic therapy (ALA-PDT) for the treatment of recalcitrant acral warts.</div></div><div><h3>Methods</h3><div>Our study was carried out between July 2023 to June 2025, and the clinical data of 50 patients diagnosed with acral warts were retrospectively collected. Patients were assigned to the curettage group (<em>n</em> = 24) or the combination group (<em>n</em> = 26) based on whether they received photodynamic therapy after curettage. The clinical response effects, recurrence rate and adverse reactions of the two groups were observed and compared.</div></div><div><h3>Results</h3><div>The cure rate in the combination group was 80.8% (21/26), which was significantly higher than 45.8% (11/24) in curettage group. The recurrence rate in the combination group was 19.2% (5/26), which was lower than 54.2% (13/24) in curettage group (<em>P</em> &lt; 0.05). After three months of follow-up, moderate pain was the main adverse reaction in both groups, and no systemic adverse reactions were observed.</div></div><div><h3>Conclusion</h3><div>Our results suggest that curettage combined with ALA-PDT is promising as a safe and effective therapy for patients with recalcitrant acral warts.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105373"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accommodation and peripheral retinal defocus in school-age myopic children 学龄近视儿童的调节与周围视网膜离焦。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-15 DOI: 10.1016/j.pdpdt.2026.105351
Simin Zhang , Riping Zhang , Tsz Kin Ng , Vishal Jhanji , Jinyu Li

Background

To investigate the influences of accommodation on peripheral retinal defocus in school-age children with corrective glasses before and after cycloplegia.

Methods

In total, 69 children, aged 7–12 years, with spherical equivalent between +1.75 D and -9.75 D were recruited. Peripheral retinal defocus values (RDV) before and after cycloplegia were measured using multispectral refraction tomography (MRT), and compared among different severities of myopia. The correlation between retinal defocus and axial length was also evaluated. The parameters were measured in different circular areas (15°, 30°, 45°, and 53°), annular areas (15°-30°, 30°-45°, and 45°-53°), and quadrants (superior, inferior, temporal, and nasal). Data was obtained from the right eyes of all participants. An average of three values was used for analysis.

Results

Before cycloplegia, significant variations were identified in the inferior retinal quadrant across different severities of myopia and age groups. After cycloplegia, multiple retinal areas showed significant differences among different severities of myopia, while there were no differences in each area among different age groups. After cycloplegia, retinal defocus shifted significantly towards more hyperopic across all areas, except for the RDV-15° area. Superior retinal defocus was positively correlated with axial length before and after cycloplegia, whereas inferior retinal defocus was negatively correlated with axial length before cycloplegia.

Conclusion

This study revealed various distribution of defocus across different retinal areas in school-age children. Peripheral retinal defocus can be induced with cycloplegia. Alterations in accommodation can influence peripheral retinal defocus in school-age children.
背景:探讨调节对学龄儿童睫状体麻痹前后配戴矫正眼镜后周围视网膜离焦的影响。方法:共招募69名7-12岁儿童,年龄在+1.75 D ~ -9.75 D之间。采用多光谱折射体层摄影(MRT)技术测量眼睫状体麻痹前后视网膜离焦值(RDV),并比较不同程度近视患者之间的差异。视网膜离焦与眼轴长度的关系也被评估。在不同的圆形区域(15°、30°、45°和53°)、环形区域(15°-30°、30°-45°和45°-53°)和象限(上、下、颞和鼻)测量参数。数据来自所有参与者的右眼。使用三个值的平均值进行分析。结果:在睫状体麻痹前,视网膜下象限在不同近视严重程度和年龄组之间存在显著差异。睫状体麻痹后,不同程度近视患者视网膜多区域差异有统计学意义,不同年龄组各区域差异无统计学意义。在睫状体麻痹后,除RDV-15o区域外,视网膜离焦在所有区域都明显向远视方向转移。上视网膜离焦与截瘫前后眼轴长度呈正相关,下视网膜离焦与截瘫前眼轴长度呈负相关。结论:本研究揭示了学龄儿童视网膜不同区域散焦的不同分布。周围视网膜离焦可由睫状体麻痹引起。调节的改变可影响学龄儿童周围视网膜离焦。
{"title":"Accommodation and peripheral retinal defocus in school-age myopic children","authors":"Simin Zhang ,&nbsp;Riping Zhang ,&nbsp;Tsz Kin Ng ,&nbsp;Vishal Jhanji ,&nbsp;Jinyu Li","doi":"10.1016/j.pdpdt.2026.105351","DOIUrl":"10.1016/j.pdpdt.2026.105351","url":null,"abstract":"<div><h3>Background</h3><div>To investigate the influences of accommodation on peripheral retinal defocus in school-age children with corrective glasses before and after cycloplegia.</div></div><div><h3>Methods</h3><div>In total, 69 children, aged 7–12 years, with spherical equivalent between +1.75 D and -9.75 D were recruited. Peripheral retinal defocus values (RDV) before and after cycloplegia were measured using multispectral refraction tomography (MRT), and compared among different severities of myopia. The correlation between retinal defocus and axial length was also evaluated. The parameters were measured in different circular areas (15°, 30°, 45°, and 53°), annular areas (15°-30°, 30°-45°, and 45°-53°), and quadrants (superior, inferior, temporal, and nasal). Data was obtained from the right eyes of all participants. An average of three values was used for analysis.</div></div><div><h3>Results</h3><div>Before cycloplegia, significant variations were identified in the inferior retinal quadrant across different severities of myopia and age groups. After cycloplegia, multiple retinal areas showed significant differences among different severities of myopia, while there were no differences in each area among different age groups. After cycloplegia, retinal defocus shifted significantly towards more hyperopic across all areas, except for the RDV-15° area. Superior retinal defocus was positively correlated with axial length before and after cycloplegia, whereas inferior retinal defocus was negatively correlated with axial length before cycloplegia.</div></div><div><h3>Conclusion</h3><div>This study revealed various distribution of defocus across different retinal areas in school-age children. Peripheral retinal defocus can be induced with cycloplegia. Alterations in accommodation can influence peripheral retinal defocus in school-age children.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105351"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145994178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes following transurethral laser ablation with topical versus general or spinal anesthesia for non–muscle-invasive bladder cancer: A Japanese single-center pilot study 局部麻醉、全身麻醉或脊髓麻醉经尿道激光消融治疗非肌肉侵袭性膀胱癌的临床结果:一项日本单中心试点研究
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-31 DOI: 10.1016/j.pdpdt.2026.105376
Shinkuro Yamamoto , Satoshi Fukata , Sho Shimasaki , Yoshitaka Kurano , Erika Yamashita , Kaya Atagi , Ryu Shigehisa , Hiroto Osakabe , Tomoya Nao , Tsutomu Shimamoto , Hideo Fukuhara , Nobutaka Shimizu , Shingo Ashida , Keiji Inoue

Objectives

To compare transurethral laser ablation (TULA) outcomes for non-muscle invasive bladder cancer (NMIBC) performed under topical anesthesia versus general or spinal anesthesia in a Japanese cohort.

Methods

We retrospectively reviewed 28 patients who underwent 32 TULA sessions with a 980-nm diode laser from February 2024 to June 2025. Patients treated between February and October 2024 received TULA under general or spinal anesthesia (general or spinal anesthesia group, n = 14). Those treated between October 2024 and June 2025 underwent TULA with topical lidocaine lubrication (topical anesthesia group, n = 18). We compared demographic, perioperative, and short-term oncologic outcomes. Complications were graded according to Clavien–Dindo classification.

Results

Baseline characteristics were similar between groups. Operation time, treatment energy, and treatment duration were comparable. The topical anesthesia group experienced a significantly shorter median post-treatment hospital stay (1 [1–1] vs. 2 [2–2.75] days; p < 0.001) and catheterization duration (0 [0–0] vs. 1 [1–1] days; p < 0.001). Complications were mild (grade 1–2), affecting one general or spinal anesthesia group patient (7.1%) and three topical anesthesia group patients (16.7%). Under strict follow-up criteria (≥90 and ≥180 days), 3-month recurrence-free survival (RFS) was 100% (14/14) in both groups, and 6-month RFS was 92.3% (12/13) in the anesthesia group vs. 58.3% (7/12) in the topical anesthesia group. Kaplan–Meier analysis showed no statistically significant difference (p = 0.19).

Conclusions

TULA under topical anesthesia for selected NMIBC patients was associated with shorter post-treatment hospital stays and a catheter-free recovery. Early oncologic outcomes, including short-term RFS, seem promising; however, these preliminary, pilot-scale findings warrant further validation in larger studies. TULA with topical anesthesia may provide perioperative advantages compared with procedures performed under general or spinal anesthesia, particularly in older patients or those with significant comorbidities.
目的:比较一项日本队列研究中,表面麻醉与全身麻醉或脊髓麻醉下经尿道激光消融(TULA)治疗非肌肉浸润性膀胱癌(NMIBC)的结果。方法:我们回顾性分析了从2024年2月至2025年6月接受32次980纳米二极管激光TULA治疗的28例患者。2024年2月至10月接受全麻或脊髓麻醉下TULA治疗的患者(全麻或脊髓麻醉组,n = 14)。在2024年10月至2025年6月期间接受TULA治疗的患者采用局部利多卡因润滑(表面麻醉组,n = 18)。我们比较了人口统计学、围手术期和短期肿瘤预后。并发症按Clavien-Dindo分级。结果:两组间基线特征相似。手术时间、治疗能量、治疗时间具有可比性。表面麻醉组治疗后中位住院时间(1[1-1]比2[2-2.75]天,p < 0.001)和置管时间(0[0-0]比1[1-1]天,p < 0.001)显著缩短。并发症轻度(1-2级),全身或脊髓麻醉组1例(7.1%),表面麻醉组3例(16.7%)。在严格的随访标准(≥90天和≥180天)下,两组患者3个月无复发生存率(RFS)均为100%(14/14),麻醉组6个月RFS为92.3%(12/13),表面麻醉组为58.3%(7/12)。Kaplan-Meier分析显示差异无统计学意义(p = 0.19)。结论:局部麻醉下的TULA与NMIBC患者治疗后住院时间缩短和无导管恢复相关。包括短期RFS在内的早期肿瘤预后似乎很有希望;然而,这些初步的、中试规模的发现需要在更大规模的研究中进一步验证。与全身麻醉或脊髓麻醉相比,表面麻醉下的TULA可提供围手术期优势,特别是对于老年患者或有明显合并症的患者。
{"title":"Clinical outcomes following transurethral laser ablation with topical versus general or spinal anesthesia for non–muscle-invasive bladder cancer: A Japanese single-center pilot study","authors":"Shinkuro Yamamoto ,&nbsp;Satoshi Fukata ,&nbsp;Sho Shimasaki ,&nbsp;Yoshitaka Kurano ,&nbsp;Erika Yamashita ,&nbsp;Kaya Atagi ,&nbsp;Ryu Shigehisa ,&nbsp;Hiroto Osakabe ,&nbsp;Tomoya Nao ,&nbsp;Tsutomu Shimamoto ,&nbsp;Hideo Fukuhara ,&nbsp;Nobutaka Shimizu ,&nbsp;Shingo Ashida ,&nbsp;Keiji Inoue","doi":"10.1016/j.pdpdt.2026.105376","DOIUrl":"10.1016/j.pdpdt.2026.105376","url":null,"abstract":"<div><h3>Objectives</h3><div>To compare transurethral laser ablation (TULA) outcomes for non-muscle invasive bladder cancer (NMIBC) performed under topical anesthesia versus general or spinal anesthesia in a Japanese cohort.</div></div><div><h3>Methods</h3><div>We retrospectively reviewed 28 patients who underwent 32 TULA sessions with a 980-nm diode laser from February 2024 to June 2025. Patients treated between February and October 2024 received TULA under general or spinal anesthesia (general or spinal anesthesia group, <em>n</em> = 14). Those treated between October 2024 and June 2025 underwent TULA with topical lidocaine lubrication (topical anesthesia group, <em>n</em> = 18). We compared demographic, perioperative, and short-term oncologic outcomes. Complications were graded according to Clavien–Dindo classification.</div></div><div><h3>Results</h3><div>Baseline characteristics were similar between groups. Operation time, treatment energy, and treatment duration were comparable. The topical anesthesia group experienced a significantly shorter median post-treatment hospital stay (1 [1–1] vs. 2 [2–2.75] days; <em>p</em> &lt; 0.001) and catheterization duration (0 [0–0] vs. 1 [1–1] days; <em>p</em> &lt; 0.001). Complications were mild (grade 1–2), affecting one general or spinal anesthesia group patient (7.1%) and three topical anesthesia group patients (16.7%). Under strict follow-up criteria (≥90 and ≥180 days), 3-month recurrence-free survival (RFS) was 100% (14/14) in both groups, and 6-month RFS was 92.3% (12/13) in the anesthesia group vs. 58.3% (7/12) in the topical anesthesia group. Kaplan–Meier analysis showed no statistically significant difference (<em>p</em> = 0.19).</div></div><div><h3>Conclusions</h3><div>TULA under topical anesthesia for selected NMIBC patients was associated with shorter post-treatment hospital stays and a catheter-free recovery. Early oncologic outcomes, including short-term RFS, seem promising; however, these preliminary, pilot-scale findings warrant further validation in larger studies. TULA with topical anesthesia may provide perioperative advantages compared with procedures performed under general or spinal anesthesia, particularly in older patients or those with significant comorbidities.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105376"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146109262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifungal susceptibility testing and clinical efficacy observation of methylene blue photodynamic therapy in treating trichophyton indotineae infections 亚甲基蓝光动力疗法治疗印支毛癣菌感染的药敏试验及临床疗效观察。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-21 DOI: 10.1016/j.pdpdt.2026.105363
Wei-Lun Xu , Gao-Yuan Peng , Shu-Lei Qin , Yan-Qing Zheng , Jia-Can Huang , Jun-Meng Zhou , Ming-Yu Zheng , Dong-Yan Zheng , Xinyu Zhang
Superficial fungal infections caused by Trichophyton indotineae are spreading globally, with mutations in its SQLE gene (F397L/L393S) increasing resistance to traditional antifungals like terbinafine, creating an urgent need for new therapies. This study evaluated the clinical efficacy of methylene blue-mediated photodynamic therapy (MB-PDT). In vitro susceptibility testing was performed on a multidrug-resistant T. indotineae strain isolated from a 25-year-old Indian male with extensive skin lesions (confirmed by ITS sequencing). A randomized controlled trial was conducted: the experimental group (forearm lesions) received topical 1 % methylene blue plus 630 ± 5 nm red light irradiation (100 J/cm², once weekly for 4 weeks), while the control group (other lesions) were treated with topical 1 % terbinafine cream twice daily. Results showed the strain was highly sensitive to methylene blue (MIC = 1.0 μg/mL) but resistant to terbinafine (MIC = 8.0 μg/mL). After 2 weeks, the experimental group achieved scaling resolution and negative fungal microscopy, with sustained efficacy at 4 weeks; the control group retained residual hyphae. Conclusion: MB-PDT rapidly eradicates drug-resistant T. indotineae infections, outperforming traditional topical agents and providing a safe, effective alternative for drug-resistant dermatophytosis.
indodoineae毛癣菌引起的浅表真菌感染正在全球蔓延,其SQLE基因(F397L/L393S)突变增加了对特比萘芬等传统抗真菌药物的耐药性,迫切需要新的治疗方法[10]。本研究评估了亚甲基蓝介导的光动力疗法(MB-PDT)的临床疗效。对从一名25岁印度男性广泛皮肤病变(经ITS测序证实)中分离出的一株多重耐药的印dotineae菌株进行了体外药敏试验。采用随机对照试验,实验组(前臂病变)给予1%亚甲基蓝+ 630±5nm红光照射(100 J/cm²,每周1次,连用4周),对照组(其他病变)给予1%特比萘芬乳膏,每日2次。结果表明,该菌株对亚甲蓝(MIC=1.0 μg/mL)高度敏感,对特比萘芬(MIC=8.0 μg/mL)耐药。2周后,实验组达到清垢分辨率和真菌镜检阴性,4周持续有效;对照组菌丝残留。结论:MB-PDT可快速根除耐药的indottineae感染,优于传统的外用药物,为耐药的皮肤真菌病提供了一种安全有效的替代方法。
{"title":"Antifungal susceptibility testing and clinical efficacy observation of methylene blue photodynamic therapy in treating trichophyton indotineae infections","authors":"Wei-Lun Xu ,&nbsp;Gao-Yuan Peng ,&nbsp;Shu-Lei Qin ,&nbsp;Yan-Qing Zheng ,&nbsp;Jia-Can Huang ,&nbsp;Jun-Meng Zhou ,&nbsp;Ming-Yu Zheng ,&nbsp;Dong-Yan Zheng ,&nbsp;Xinyu Zhang","doi":"10.1016/j.pdpdt.2026.105363","DOIUrl":"10.1016/j.pdpdt.2026.105363","url":null,"abstract":"<div><div>Superficial fungal infections caused by Trichophyton indotineae are spreading globally, with mutations in its SQLE gene (F397L/L393S) increasing resistance to traditional antifungals like terbinafine, creating an urgent need for new therapies. This study evaluated the clinical efficacy of methylene blue-mediated photodynamic therapy (MB-PDT). In vitro susceptibility testing was performed on a multidrug-resistant T. indotineae strain isolated from a 25-year-old Indian male with extensive skin lesions (confirmed by ITS sequencing). A randomized controlled trial was conducted: the experimental group (forearm lesions) received topical 1 % methylene blue plus 630 ± 5 nm red light irradiation (100 J/cm², once weekly for 4 weeks), while the control group (other lesions) were treated with topical 1 % terbinafine cream twice daily. Results showed the strain was highly sensitive to methylene blue (MIC = 1.0 μg/mL) but resistant to terbinafine (MIC = 8.0 μg/mL). After 2 weeks, the experimental group achieved scaling resolution and negative fungal microscopy, with sustained efficacy at 4 weeks; the control group retained residual hyphae. Conclusion: MB-PDT rapidly eradicates drug-resistant T. indotineae infections, outperforming traditional topical agents and providing a safe, effective alternative for drug-resistant dermatophytosis.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105363"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Photodynamic therapy combined with systemic treatment achieves significant remission in microsatellite instability-high locally advanced colorectal cancer: A case report and literature review 光动力联合全身治疗微卫星不稳定性高局部晚期结直肠癌1例并文献复习
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-22 DOI: 10.1016/j.pdpdt.2026.105361
Jingwei Ma , Jike Hu , Yali Li , Lingzhi Liao , Jing Liu , Yile Qi , Jiahui Ma , Lin Xiang , Hao Chen
Patients with locally advanced colorectal cancer (LACRC) are at high risk of recurrence and metastasis and benefit little from neoadjuvant radiotherapy (nCRT) or neoadjuvant chemotherapy (nCT). Although the Microsatellite instability-high (MSI-H) status has been identified as a valid predictive marker for immunotherapy response, heterogeneity in the treatment response remains. In this study, we report a case of a 70-year-old woman with locally advanced rectal cancer with MSI-H status who had no chance of surgery due to tumor invasion of the uterine wall (cT3N2Mx) and who underwent a systemic treatment regimen of photodynamic therapy (PDT) in combination with a PD-1 inhibitor and antiangiogenic therapy. The treatment consisted of four tumor-directed PDT sessions and a 6-cycle systemic regimen (sintilimab/tislelizumab 200 mg/q3W combined with bevacizumab 7.5 mg/kg/q3W and capecitabine 1000 mg/m2). After six cycles, the tumor achieved near-complete remission, with negative mesorectal fascia (MRF) and extramural vascular invasion (EMVI) status. As of the most recent telephone follow-up prior to manuscript submission, the patient remained progression-free for 17 months. This case demonstrates the synergistic efficacy of PDT combined with immune-targeted therapy in MSI-H LACRC, offering a novel non-surgical treatment option for organ preservation in such patients.
局部晚期结直肠癌(LACRC)是复发和转移的高危患者,新辅助放疗(nCRT)或新辅助化疗(nCT)的疗效甚微。尽管微卫星不稳定-高(MSI-H)状态已被确定为免疫治疗反应的有效预测标志物,但治疗反应的异质性仍然存在。在这项研究中,我们报告了一例70岁的局部晚期直肠癌伴MSI-H状态的妇女,由于肿瘤侵袭子宫壁(cT3N2Mx)而无法手术,她接受了光动力治疗(PDT)联合PD-1抑制剂和抗血管生成治疗的全身治疗方案。治疗包括4个肿瘤导向的PDT疗程和6个周期的全身方案(sintilimab/tislelizumab 200 mg/q3W联合贝伐单抗7.5 mg/kg/q3W和卡培他滨1000 mg/m2)。六个周期后,肿瘤几乎完全缓解,直肠系膜筋膜(MRF)和外血管侵袭(EMVI)状态为阴性。在提交论文前的最近一次电话随访中,患者无进展17个月。该病例证明了PDT联合免疫靶向治疗在MSI-H LACRC中的协同作用,为这类患者的器官保存提供了一种新的非手术治疗选择。
{"title":"Photodynamic therapy combined with systemic treatment achieves significant remission in microsatellite instability-high locally advanced colorectal cancer: A case report and literature review","authors":"Jingwei Ma ,&nbsp;Jike Hu ,&nbsp;Yali Li ,&nbsp;Lingzhi Liao ,&nbsp;Jing Liu ,&nbsp;Yile Qi ,&nbsp;Jiahui Ma ,&nbsp;Lin Xiang ,&nbsp;Hao Chen","doi":"10.1016/j.pdpdt.2026.105361","DOIUrl":"10.1016/j.pdpdt.2026.105361","url":null,"abstract":"<div><div>Patients with locally advanced colorectal cancer (LACRC) are at high risk of recurrence and metastasis and benefit little from neoadjuvant radiotherapy (nCRT) or neoadjuvant chemotherapy (nCT). Although the Microsatellite instability-high (MSI-H) status has been identified as a valid predictive marker for immunotherapy response, heterogeneity in the treatment response remains. In this study, we report a case of a 70-year-old woman with locally advanced rectal cancer with MSI-H status who had no chance of surgery due to tumor invasion of the uterine wall (cT3N2Mx) and who underwent a systemic treatment regimen of photodynamic therapy (PDT) in combination with a PD-1 inhibitor and antiangiogenic therapy. The treatment consisted of four tumor-directed PDT sessions and a 6-cycle systemic regimen (sintilimab/tislelizumab 200 mg/q3W combined with bevacizumab 7.5 mg/kg/q3W and capecitabine 1000 mg/m<sup>2</sup>). After six cycles, the tumor achieved near-complete remission, with negative mesorectal fascia (MRF) and extramural vascular invasion (EMVI) status. As of the most recent telephone follow-up prior to manuscript submission, the patient remained progression-free for 17 months. This case demonstrates the synergistic efficacy of PDT combined with immune-targeted therapy in MSI-H LACRC, offering a novel non-surgical treatment option for organ preservation in such patients.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105361"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision conversion of colorectal cancer lung metastases: A personalized quadruplet regimen integrating photodynamic therapy with targeted, immunotherapy, and chemotherapy 结直肠癌肺转移的精确转化:将光动力治疗与靶向、免疫治疗和化疗相结合的个性化四联体方案。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-22 DOI: 10.1016/j.pdpdt.2026.105362
Qinying Han , Lei Gao , Yunpeng Wang , Zhuanfang Wang , Lijuan He , Ben Liu , Jike Hu , Bo Xu , Hao Chen

Significance

Colorectal cancer (CRC) has a high incidence and mortality rate, with lung metastasis being the second most common site. Current treatments have limited efficacy, and novel approaches are needed.

Approach

We report a case of a middle-aged female with CRC and lung metastasis treated with four cycles of PDT and five cycles of systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

Results

After treatment, the lung metastases showed cystic changes, and the primary tumor significantly regressed (TRG: AJCC 0, Becker 1a). The patient successfully underwent surgical treatment.

Conclusions

This multimodal therapy shows promise in CRC lung metastasis, offering new insights for treatment.
意义:结直肠癌(Colorectal cancer, CRC)具有较高的发病率和死亡率,肺转移是第二常见的转移部位。目前的治疗方法疗效有限,需要新的治疗方法。方法:我们报告一例中年女性结直肠癌合并肺转移患者,接受4个周期的PDT治疗和5个周期的全身治疗,包括化疗、靶向治疗和免疫治疗。结果:治疗后肺转移灶呈囊性改变,原发肿瘤明显消退(TRG: AJCC 0, Becker 1a)。病人成功地接受了手术治疗。结论:这种多模式治疗在结直肠癌肺转移中有希望,为治疗提供了新的见解。该病例是第一例PDT联合全身治疗的报道。
{"title":"Precision conversion of colorectal cancer lung metastases: A personalized quadruplet regimen integrating photodynamic therapy with targeted, immunotherapy, and chemotherapy","authors":"Qinying Han ,&nbsp;Lei Gao ,&nbsp;Yunpeng Wang ,&nbsp;Zhuanfang Wang ,&nbsp;Lijuan He ,&nbsp;Ben Liu ,&nbsp;Jike Hu ,&nbsp;Bo Xu ,&nbsp;Hao Chen","doi":"10.1016/j.pdpdt.2026.105362","DOIUrl":"10.1016/j.pdpdt.2026.105362","url":null,"abstract":"<div><h3>Significance</h3><div>Colorectal cancer (CRC) has a high incidence and mortality rate, with lung metastasis being the second most common site. Current treatments have limited efficacy, and novel approaches are needed.</div></div><div><h3>Approach</h3><div>We report a case of a middle-aged female with CRC and lung metastasis treated with four cycles of PDT and five cycles of systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.</div></div><div><h3>Results</h3><div>After treatment, the lung metastases showed cystic changes, and the primary tumor significantly regressed (TRG: AJCC 0, Becker 1a). The patient successfully underwent surgical treatment.</div></div><div><h3>Conclusions</h3><div>This multimodal therapy shows promise in CRC lung metastasis, offering new insights for treatment.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105362"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergistic effect of photodynamic therapy with multimodal therapy achieves anus preservation in MSS ultra-low rectal cancer—A case report and literature review 光动力治疗与多模式治疗的协同作用在MSS超低直肠癌中实现肛门保留1例报告并文献复习。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2025-11-25 DOI: 10.1016/j.pdpdt.2025.105299
Jing Liu , Lingzhi Liao , Jiahui Ma , Jingwei Ma , Yali Li , Yile Qi , Baohong Gu , Jike Hu , Ewetse Paul Maswikiti , Hao Chen
The preservation of the anus in ultra-low rectal cancer (ULRC) surgery presents considerable clinical challenges. While combined neoadjuvant therapy is considered a pivotal treatment strategy, its effectiveness is constrained by factors such as anatomical location, postoperative complications, systemic toxic reactions, and tumor drug resistance. Photodynamic therapy (PDT), as a localized treatment modality, operates through multiple mechanisms, including the targeted eradication of tumor cells, disruption of the tumor vascular system, reversal of drug resistance, and activation of antitumor immune responses. This article presents a case study of a patient with stage IIIb (cT4N1Mx), microsatellite stable (MSS) ULRC, who successfully achieved tumor downstaging and underwent anus-preserving surgery following a comprehensive treatment regimen. This regimen included PDT, systemic therapy, da Vinci robot-assisted anus-preserving surgery, and anastomotic stent implantation. The patient has achieved a progression-free survival (PFS) exceeding 14 months. At present, the patient exhibits satisfactory defecation function, and no complications, such as anastomotic fistula, have been observed.
超低位直肠癌(ULRC)手术中肛门的保存提出了相当大的临床挑战。虽然联合新辅助治疗被认为是一种关键的治疗策略,但其有效性受到解剖学位置、术后并发症、全身毒性反应和肿瘤耐药等因素的限制。光动力疗法(PDT)作为一种局部治疗方式,通过多种机制起作用,包括靶向根除肿瘤细胞、破坏肿瘤血管系统、增强耐药、激活抗肿瘤免疫反应等。本文报道了一例IIIb期(cT4N1Mx)微卫星稳定型(MSS) ULRC患者的病例研究,该患者在综合治疗方案后成功实现肿瘤降期并接受了保肛手术。该方案包括PDT、全身治疗、达芬奇机器人辅助肛门保留手术和吻合口支架植入。患者的无进展生存期(PFS)超过14个月。目前患者排便功能良好,未见吻合口瘘等并发症。
{"title":"Synergistic effect of photodynamic therapy with multimodal therapy achieves anus preservation in MSS ultra-low rectal cancer—A case report and literature review","authors":"Jing Liu ,&nbsp;Lingzhi Liao ,&nbsp;Jiahui Ma ,&nbsp;Jingwei Ma ,&nbsp;Yali Li ,&nbsp;Yile Qi ,&nbsp;Baohong Gu ,&nbsp;Jike Hu ,&nbsp;Ewetse Paul Maswikiti ,&nbsp;Hao Chen","doi":"10.1016/j.pdpdt.2025.105299","DOIUrl":"10.1016/j.pdpdt.2025.105299","url":null,"abstract":"<div><div>The preservation of the anus in ultra-low rectal cancer (ULRC) surgery presents considerable clinical challenges. While combined neoadjuvant therapy is considered a pivotal treatment strategy, its effectiveness is constrained by factors such as anatomical location, postoperative complications, systemic toxic reactions, and tumor drug resistance. Photodynamic therapy (PDT), as a localized treatment modality, operates through multiple mechanisms, including the targeted eradication of tumor cells, disruption of the tumor vascular system, reversal of drug resistance, and activation of antitumor immune responses. This article presents a case study of a patient with stage IIIb (cT4N1Mx), microsatellite stable (MSS) ULRC, who successfully achieved tumor downstaging and underwent anus-preserving surgery following a comprehensive treatment regimen. This regimen included PDT, systemic therapy, da Vinci robot-assisted anus-preserving surgery, and anastomotic stent implantation. The patient has achieved a progression-free survival (PFS) exceeding 14 months. At present, the patient exhibits satisfactory defecation function, and no complications, such as anastomotic fistula, have been observed.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105299"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal structural alterations in patients with type 2 diabetes mellitus without clinical diabetic retinopathy using ultra-widefield swept-source OCTA: A cross-sectional study 超宽视场扫描源OCTA对无临床糖尿病视网膜病变的2型糖尿病患者脉络膜结构改变的横断面研究
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-15 DOI: 10.1016/j.pdpdt.2026.105349
Cong Chen , Wen-Jing Zhang , Qin Ding , Shu-Min Shen , Ya Ye , Zhen Huang , Ming Yan , Yan-Ping Song

Objective

This study aimed to quantitatively examine choroidal structural alterations in patients with type 2 diabetes mellitus (T2DM) of varying disease duration who did not present with clinical diabetic retinopathy (DR), using ultra-widefield swept-source optical coherence tomography angiography (UWF-SS-OCTA).

Methods

This cross-sectional study included 200 patients with T2DM without DR (200 eyes) and 78 healthy individuals (78 eyes). Based on diabetes duration, patients were categorized into three groups: <5 years (DM1, n = 80), 5 to 10 years (DM2, n = 60), and >10 years (DM3, n = 60). UWF-SS-OCTA was used to quantify choroidal thickness (CT), choroidal vascular volume (CVV), and choroidal vascularity index (CVI) in the peripapillary region, the macula-centered UWF central area (1–12 mm), and the peripheral area (12–21 mm). One-way analysis of variance with post hoc testing assessed intergroup differences. Multivariable linear regression was performed to evaluate the associations between diabetes duration and choroidal parameters.

Results

Relative to healthy controls, patients in the DM3 group exhibited significant reductions in CT and CVV in all evaluated regions, along with decreases in CVI in most regions (all p < 0.05). When diabetic subgroups were compared, the DM3 group demonstrated significantly lower CT and CVV across all regions compared with the DM1 and DM2 groups (all p < 0.05). Central CVI showed a progressive decline with longer diabetes duration, while peripheral CVI differed significantly only between the DM3 and DM1 groups. Except for peripheral CVI, CT, CVV, and central CVI across all assessed regions were independently and negatively associated with diabetes duration (all p < 0.05).

Conclusion

Patients with T2DM without DR demonstrated early choroidal thinning and vascular deterioration, which progressively worsened with longer diabetes duration. UWF-SS-OCTA revealed that the choroidal alterations in T2DM without DR were widespread but most pronounced in the peripheral regions, highlighting the importance of wide-field imaging for comprehensive assessment.
目的:本研究旨在利用超宽视场扫描源光学相干断层扫描血管造影(UWF-SS-OCTA)定量检测未出现临床糖尿病视网膜病变(DR)的不同病程的2型糖尿病(T2DM)患者的脉络膜结构改变。方法:本横断面研究纳入200例无DR的T2DM患者(200眼)和78例健康人(78眼)。根据糖尿病病程将患者分为3组:小于5年(DM1, n = 80),5 ~ 10年(DM2, n = 60),10年以上(DM3, n = 60)。UWF- ss - octa量化乳头周围区、以黄斑为中心的UWF中心区(1-12 mm)和周围区(12-21 mm)的脉络膜厚度(CT)、脉络膜血管体积(CVV)和脉络膜血管指数(CVI)。单因素方差分析和事后检验评估组间差异。采用多变量线性回归来评估糖尿病病程与脉络膜参数之间的关系。结果:与健康对照组相比,DM3组患者在所有评估区域的CT和CVV均显著降低,大部分区域的CVI均降低(均p < 0.05)。当对糖尿病亚组进行比较时,与DM1和DM2组相比,DM3组在所有区域的CT和CVV均显著降低(均p < 0.05)。随着糖尿病病程的延长,中枢性CVI逐渐下降,而外周CVI仅在DM3组和DM1组之间存在显著差异。除外周CVI外,所有评估区域的CT、CVV和中枢性CVI均与糖尿病病程呈独立负相关(均p < 0.05)。结论:无DR的T2DM患者早期表现为脉络膜变薄和血管恶化,并随着糖尿病病程的延长而进行性恶化。UWF-SS-OCTA显示无DR的T2DM患者的脉络膜改变广泛存在,但在外周区域最为明显,这突出了宽视场成像对综合评估的重要性。
{"title":"Choroidal structural alterations in patients with type 2 diabetes mellitus without clinical diabetic retinopathy using ultra-widefield swept-source OCTA: A cross-sectional study","authors":"Cong Chen ,&nbsp;Wen-Jing Zhang ,&nbsp;Qin Ding ,&nbsp;Shu-Min Shen ,&nbsp;Ya Ye ,&nbsp;Zhen Huang ,&nbsp;Ming Yan ,&nbsp;Yan-Ping Song","doi":"10.1016/j.pdpdt.2026.105349","DOIUrl":"10.1016/j.pdpdt.2026.105349","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to quantitatively examine choroidal structural alterations in patients with type 2 diabetes mellitus (T2DM) of varying disease duration who did not present with clinical diabetic retinopathy (DR), using ultra-widefield swept-source optical coherence tomography angiography (UWF-SS-OCTA).</div></div><div><h3>Methods</h3><div>This cross-sectional study included 200 patients with T2DM without DR (200 eyes) and 78 healthy individuals (78 eyes). Based on diabetes duration, patients were categorized into three groups: &lt;5 years (DM1, <em>n</em> = 80), 5 to 10 years (DM2, <em>n</em> = 60), and &gt;10 years (DM3, <em>n</em> = 60). UWF-SS-OCTA was used to quantify choroidal thickness (CT), choroidal vascular volume (CVV), and choroidal vascularity index (CVI) in the peripapillary region, the macula-centered UWF central area (1–12 mm), and the peripheral area (12–21 mm). One-way analysis of variance with post hoc testing assessed intergroup differences. Multivariable linear regression was performed to evaluate the associations between diabetes duration and choroidal parameters.</div></div><div><h3>Results</h3><div>Relative to healthy controls, patients in the DM3 group exhibited significant reductions in CT and CVV in all evaluated regions, along with decreases in CVI in most regions (all <em>p</em> &lt; 0.05). When diabetic subgroups were compared, the DM3 group demonstrated significantly lower CT and CVV across all regions compared with the DM1 and DM2 groups (all <em>p</em> &lt; 0.05). Central CVI showed a progressive decline with longer diabetes duration, while peripheral CVI differed significantly only between the DM3 and DM1 groups. Except for peripheral CVI, CT, CVV, and central CVI across all assessed regions were independently and negatively associated with diabetes duration (all <em>p</em> &lt; 0.05).</div></div><div><h3>Conclusion</h3><div>Patients with T2DM without DR demonstrated early choroidal thinning and vascular deterioration, which progressively worsened with longer diabetes duration. UWF-SS-OCTA revealed that the choroidal alterations in T2DM without DR were widespread but most pronounced in the peripheral regions, highlighting the importance of wide-field imaging for comprehensive assessment.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105349"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145991994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic analysis reveals the molecular mechanisms of methylene blue-mediated photodynamic therapy against Microsporum canis 转录组学分析揭示亚甲基蓝介导的光动力治疗犬小孢子虫的分子机制。
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-01-22 DOI: 10.1016/j.pdpdt.2026.105364
Gaoyuan Peng , Weilun Xu , Shulei Qin , Junmeng Zhou , Kaisu Pan , Lan Huang , Dongyan Zheng , Xinyu Zhang

Background

Microsporum canis is a predominant cause of dermatophytosis, presenting a significant therapeutic challenge due to the limitations of conventional antifungal agents and the emergence of drug resistance. Methylene Blue-mediated Photodynamic Therapy (MB-PDT) represents a promising alternative; however, the comprehensive transcriptomic response and specific molecular pathways disrupted by this modality in M. canis remain largely elusive.

Methods

This study employed RNA-sequencing (RNA-Seq) to elucidate the global transcriptomic response of M. canis to a sub-inhibitory concentration of MB-PDT. Differentially expressed genes (DEGs) were identified, and their biological functions were characterized via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Furthermore, the expression profiles of key marker genes were validated using qRT-PCR.

Results

A total of 619 DEGs were identified, comprising 341 upregulated and 278 downregulated genes. Functional enrichment analysis highlighted the "ribosome" and "steroid biosynthesis" pathways as the most significantly impacted. The transcriptomic profile suggests that MB-PDT induces multi-target oxidative damage, specifically compromising cell membrane integrity, mitochondrial function, and ribosomal activity. Notably, the expression patterns of key marker genes indicate that M. canis activates an intrinsic programmed cell death (PCD) pathway in response to this irreparable oxidative stress.

Conclusion

Our findings suggest that MB-PDT exerts its antifungal effect against M. canis through a multi-target mechanism that overwhelms cellular repair systems, ultimately triggering the initiation of PCD. This mode of action may mitigate the risk of resistance development, underscoring MB-PDT as a potent therapeutic alternative for the management of dermatophytosis.
背景:犬小孢子菌是引起皮肤真菌病的主要原因,由于常规抗真菌药物的局限性和耐药性的出现,对治疗提出了重大挑战。亚甲基蓝介导的光动力疗法(MB-PDT)是一种很有前途的替代方案;然而,在犬支原体中,这种模式所破坏的综合转录组反应和特定的分子途径在很大程度上仍然是难以捉摸的。方法:本研究采用rna测序(RNA-Seq)来阐明犬支原体对亚抑制浓度MB-PDT的全局转录组反应。通过基因本体(GO)和京都基因与基因组百科全书(KEGG)途径富集分析鉴定了差异表达基因(DEGs),并对其生物学功能进行了表征。此外,利用qRT-PCR验证了关键标记基因的表达谱。结果:共鉴定出619个deg,其中上调基因341个,下调基因278个。功能富集分析显示,“核糖体”和“类固醇生物合成”途径受到的影响最为显著。转录组学分析表明,MB-PDT诱导多靶点氧化损伤,特别是损害细胞膜完整性、线粒体功能和核糖体活性。值得注意的是,关键标记基因的表达模式表明,犬支原体在应对这种不可修复的氧化应激时激活了内在程序性细胞死亡(PCD)途径。结论:我们的研究结果表明,MB-PDT通过一个多靶点机制来发挥其对犬支原体的抗真菌作用,该机制可以压倒细胞修复系统,最终触发PCD的启动。这种作用方式可以减轻耐药发展的风险,强调MB-PDT是治疗皮肤癣的有效替代治疗方法。
{"title":"Transcriptomic analysis reveals the molecular mechanisms of methylene blue-mediated photodynamic therapy against Microsporum canis","authors":"Gaoyuan Peng ,&nbsp;Weilun Xu ,&nbsp;Shulei Qin ,&nbsp;Junmeng Zhou ,&nbsp;Kaisu Pan ,&nbsp;Lan Huang ,&nbsp;Dongyan Zheng ,&nbsp;Xinyu Zhang","doi":"10.1016/j.pdpdt.2026.105364","DOIUrl":"10.1016/j.pdpdt.2026.105364","url":null,"abstract":"<div><h3>Background</h3><div>Microsporum canis is a predominant cause of dermatophytosis, presenting a significant therapeutic challenge due to the limitations of conventional antifungal agents and the emergence of drug resistance. Methylene Blue-mediated Photodynamic Therapy (MB-PDT) represents a promising alternative; however, the comprehensive transcriptomic response and specific molecular pathways disrupted by this modality in M. canis remain largely elusive.</div></div><div><h3>Methods</h3><div>This study employed RNA-sequencing (RNA-Seq) to elucidate the global transcriptomic response of M. canis to a sub-inhibitory concentration of MB-PDT. Differentially expressed genes (DEGs) were identified, and their biological functions were characterized via Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses. Furthermore, the expression profiles of key marker genes were validated using qRT-PCR.</div></div><div><h3>Results</h3><div>A total of 619 DEGs were identified, comprising 341 upregulated and 278 downregulated genes. Functional enrichment analysis highlighted the \"ribosome\" and \"steroid biosynthesis\" pathways as the most significantly impacted. The transcriptomic profile suggests that MB-PDT induces multi-target oxidative damage, specifically compromising cell membrane integrity, mitochondrial function, and ribosomal activity. Notably, the expression patterns of key marker genes indicate that M. canis activates an intrinsic programmed cell death (PCD) pathway in response to this irreparable oxidative stress.</div></div><div><h3>Conclusion</h3><div>Our findings suggest that MB-PDT exerts its antifungal effect against <em>M. canis</em> through a multi-target mechanism that overwhelms cellular repair systems, ultimately triggering the initiation of PCD. This mode of action may mitigate the risk of resistance development, underscoring MB-PDT as a potent therapeutic alternative for the management of dermatophytosis.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105364"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146044524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phase I/II clinical study of next-generation photodynamic therapy (L-PDT) using talaporfin sodium (Laserphyrin®) for cervical intraepithelial neoplasia: Efficacy, safety, and fertility preservation 新一代光动力疗法(L-PDT)使用塔拉波芬钠(Laserphyrin®)治疗宫颈上皮内瘤变的I/II期临床研究:有效性、安全性和生育保护
IF 2.6 3区 医学 Q2 ONCOLOGY Pub Date : 2026-04-01 Epub Date: 2026-02-02 DOI: 10.1016/j.pdpdt.2026.105372
Masaru Sakamoto , Shuji Takeda , Arisa Fujiwara , Momo Hirata , Sou Hirose , Kazuko Matsuoka , Kenji Umayahara , Keiichi Iwaya , Tadao Tanaka , Aikou Okamoto

Background

PDT using Photofrin® (P-PDT) has been applied to over 900 gynecologic tumor cases since 1989, demonstrating excellent efficacy and fertility preservation; however, post-treatment photosensitivity has limited its clinical application for CIN and cervical cancer. This study aimed to establish a safe, effective, and fertility-preserving alternative to cervical conization.

Methods

To overcome photosensitivity, we conducted a prospective Phase I/II clinical study to evaluate the safety, efficacy, oncological control, and fertility outcomes of L-PDT using talaporfin sodium (Laserphyrin®) and a diode laser for CIN grades 2–3. Forty-three women with biopsy-confirmed CIN2–3 were enrolled. Phase I determined the optimal light dose (50, 75, or 100 J/cm²), and Phase II assessed efficacy and safety at 100 J/cm². Talaporfin sodium (40 mg/m²) was administered intravenously 4 hours before laser irradiation under colposcopic guidance.

Results

Complete response (CR) was achieved in 95% (95% CI: 89.1–100%) at 3 months and 98% (95% CI: 93.2–100%) at 6 months after treatment. Original high-risk human papillomavirus clearance was 92.5% at 3 months and 95% at 12 months. Adverse events were mild and transient, including abdominal pain and low-grade fever. No recurrences occurred during a median follow-up of 66.4 months among patients achieving CR. Among women desiring pregnancy, the conception rate was 74% (23/31) and the live birth rate was 79% (27/34), with a low preterm birth rate of 3.7% (1/27). Conclusions: These results suggest that L-PDT is a safe and highly effective non-excisional treatment for CIN that may contribute to fertility preservation; however, potential advantages over conventional conization and laser vaporization need to be confirmed in comparative studies.
背景:自1989年以来,使用Photofrin®(P-PDT)的PDT已应用于900多例妇科肿瘤,显示出良好的疗效和保留生育能力;然而,治疗后光敏性限制了其在CIN和宫颈癌中的临床应用。本研究旨在建立一种安全、有效、保留生育能力的宫颈锥切术替代方法。方法:为了克服光敏性,我们进行了一项前瞻性I/II期临床研究,以评估使用塔拉波芬钠(Laserphyrin®)和二极管激光治疗2-3级CIN的L-PDT的安全性、有效性、肿瘤控制和生育结果。入选了43名活检证实为CIN2-3的女性。第一阶段确定了最佳光剂量(50、75或100 J/cm²),第二阶段评估了100 J/cm²的疗效和安全性。在阴道镜引导下,激光照射前4小时静脉给予塔拉波芬钠(40 mg/m²)。结果:治疗后3个月达到95% (95% CI: 89.1-100%)的完全缓解(CR), 6个月达到98% (95% CI: 93.2-100%)。原始高危人乳头瘤病毒清除率在3个月时为92.5%,在12个月时为95%。不良事件是轻微和短暂的,包括腹痛和低烧。实现CR的患者中位随访66.4个月无复发,期望妊娠的女性受孕率为74%(23/31),活产率为79%(27/34),低早产率为3.7%(1/27)。结论:L-PDT是一种安全、高效的非切除治疗CIN的方法,可能有助于保留生育能力;然而,相对于传统锥化和激光汽化的潜在优势需要在比较研究中得到证实。
{"title":"Phase I/II clinical study of next-generation photodynamic therapy (L-PDT) using talaporfin sodium (Laserphyrin®) for cervical intraepithelial neoplasia: Efficacy, safety, and fertility preservation","authors":"Masaru Sakamoto ,&nbsp;Shuji Takeda ,&nbsp;Arisa Fujiwara ,&nbsp;Momo Hirata ,&nbsp;Sou Hirose ,&nbsp;Kazuko Matsuoka ,&nbsp;Kenji Umayahara ,&nbsp;Keiichi Iwaya ,&nbsp;Tadao Tanaka ,&nbsp;Aikou Okamoto","doi":"10.1016/j.pdpdt.2026.105372","DOIUrl":"10.1016/j.pdpdt.2026.105372","url":null,"abstract":"<div><h3>Background</h3><div>PDT using Photofrin® (P-PDT) has been applied to over 900 gynecologic tumor cases since 1989, demonstrating excellent efficacy and fertility preservation; however, post-treatment photosensitivity has limited its clinical application for CIN and cervical cancer. This study aimed to establish a safe, effective, and fertility-preserving alternative to cervical conization.</div></div><div><h3>Methods</h3><div>To overcome photosensitivity, we conducted a prospective Phase I/II clinical study to evaluate the safety, efficacy, oncological control, and fertility outcomes of L-PDT using talaporfin sodium (Laserphyrin®) and a diode laser for CIN grades 2–3. Forty-three women with biopsy-confirmed CIN2–3 were enrolled. Phase I determined the optimal light dose (50, 75, or 100 J/cm²), and Phase II assessed efficacy and safety at 100 J/cm². Talaporfin sodium (40 mg/m²) was administered intravenously 4 hours before laser irradiation under colposcopic guidance.</div></div><div><h3>Results</h3><div>Complete response (CR) was achieved in 95% (95% CI: 89.1–100%) at 3 months and 98% (95% CI: 93.2–100%) at 6 months after treatment. Original high-risk human papillomavirus clearance was 92.5% at 3 months and 95% at 12 months. Adverse events were mild and transient, including abdominal pain and low-grade fever. No recurrences occurred during a median follow-up of 66.4 months among patients achieving CR. Among women desiring pregnancy, the conception rate was 74% (23/31) and the live birth rate was 79% (27/34), with a low preterm birth rate of 3.7% (1/27). Conclusions: These results suggest that L-PDT is a safe and highly effective non-excisional treatment for CIN that may contribute to fertility preservation; however, potential advantages over conventional conization and laser vaporization need to be confirmed in comparative studies.</div></div>","PeriodicalId":20141,"journal":{"name":"Photodiagnosis and Photodynamic Therapy","volume":"58 ","pages":"Article 105372"},"PeriodicalIF":2.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Photodiagnosis and Photodynamic Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1